Digital Media briefs: Everyday Health, HealthPrize Technologies, Boston Scientific, BBK Worldwide and PatientsLikeMe

Share this article:

Everyday Health formed an advisory board whose members include former FDA commissioner David Kessler, MD; former CBS News president Andrew Heyward; former AMA editor in chief George Lundberg, MD; physician and medical journalist Mallika Marshall, MD; Rosetta co-founder Kurt Holstein; and former Genentech president and COO Myrtle Potter.

HealthPrize Technologies launched a mobile app aimed at boosting adherence with creative rewards, games and education. The app skips reminders in favor of a gaming-inspired approach.

Boston Scientific launched its CardioTeach iPad app, aimed at helping healthcare professionals “better educate patients and care­givers about therapy options related to cardiovascular and peripheral diseases.”

BBK Worldwide and PatientsLikeMe launched CallingAllTypes.com, a social health initiative for diabetics that broadcasts posts on Facebook, YouTube and Twitter. The site's sponsors gave a dollar to the Atlanta chapter of the American Diabetes Association for each of the first 10,000 visitors posting comments in November—American Diabetes Month.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?